Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies

Little evidence is available regarding the incidence of CMV disease in patients with solid cancers. Latest data show that approximately 50 % of these patients with CMV PCR positivity developed clinically relevant CMV-viremia, and would require specific therapy. In the clinical arena, CMV reactivatio...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Bustos, Víctor, Salavert, Miguel, Blanes, Rosa, Cabañero, Dafne, Blanes, Marino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2022
Materias:
Approach to Infection in Immunosuppressed Patients
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717468/
https://www.ncbi.nlm.nih.gov/pubmed/36285863
http://dx.doi.org/10.37201/req/s03.16.2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717468/
https://www.ncbi.nlm.nih.gov/pubmed/36285863
http://dx.doi.org/10.37201/req/s03.16.2022

Ejemplares similares